Victoria Villaflor

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

Ezra E.W. Cohen, Theodore Karrison, Masha Kocherginsky et al. · Journal of Clinical Oncology · 2014 · 558 citations · Full text

Stereotactic body radiotherapy for multisite extracranial oligometastases

Joseph K. Salama, Michael D. Hasselle, Steven J. Chmura et al. · Cancer · 2011 · 321 citations

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Tanguy Y. Seiwert, Corey C. Foster, Elizabeth A. Blair et al. · Annals of Oncology · 2018 · 220 citations · Full text

Phase 2 study of sunitinib in refractory thyroid cancer

Ezra E.W. Cohen, Burton Needles, K. J. Cullen et al. · Journal of Clinical Oncology · 2008 · 148 citations

Thyroid Cancers, Surgical Oncology, Pathology +19

DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Ezra E.W. Cohen, Theodore Karrison, Masha Kocherginsky et al. · Journal of Clinical Oncology · 2012 · 135 citations

Squamous Cell Carcinoma, Same Crt, Pathology +19